OpenBilldrug price receipt

NADAC week of 2026-10-14

METHOCARBAMOL 1,000 MG TABLET

For 30 tablets

Pharmacies pay

$250.44 filed

30 × $8.348 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$4.61 filed

30 × $0.15377 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.02× estimated

These two figures may not measure the same thing

At 0.02×, the Medicare figure is 0.2 times what pharmacies pay or less. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.

This product’s middle NADAC price, $8.348 per EA, is 212× the middle NADAC price of the 2 other products CMS averages under “Methocarbamol*” / “Methocarbamol” ($0.03946 per EA), so the Part D average may mostly describe those products, not this one.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-05-20 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$293.01 estimated

$250.44 + $37.57 (15%) + $5.00 fee per fill = $293.01

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-05-20 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

METHOCARBAMOL 1,000 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as methocarbamol.

FDA gives its dosage form as tablet, coated and its route as oral.

Its labelers, the companies named on the label, are Trifluent Pharma LLC and Oncora Pharma, LLC.

FDA’s Established Pharmacologic Class for it is Muscle Relaxant.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $250.44 for 30 tablets (30 × $8.348 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-05-20. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-05-20. The file is new; the price is not.

All 2 NDCs

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name methocarbamol with METHOCARBAMOL 1,000 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
METHOCARBAMOL 1,000 MG TABLET this page
generic · tablet, coated
$8.348 per EA filed
eff. 2026-05-20
$0.15377 per EA filed
Part D 2024 average
METHOCARBAMOL 500 MG TABLET
generic · tablet / tablet, film coated / tablet, coated
$0.03946 per EA filed
eff. 2026-09-23
$0.15377 per EA filed
Part D 2024 average
METHOCARBAMOL 750 MG TABLET
generic · tablet / tablet, film coated / tablet, coated
$0.04311 per EA filed
eff. 2026-09-23
$0.15377 per EA filed
Part D 2024 average
TANLOR 1,000 MG TABLET
generic · tablet, film coated
$8.348 per EA filed
eff. 2026-05-20
$19.3471 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $8.348 per EA filed.

Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 4 have a higher middle NADAC price and 17 a lower one; 1 has the same. The one in the middle is CARISOPRODOL 250 MG TABLET, at $0.47389 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $4.61 for 30 tablets, at an average of $0.15377 per EA in 2024 (2024-01-01 to 2024-12-31) for “Methocarbamol*” and “Methocarbamol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,190,991 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for METHOCARBAMOL 1,000 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: Part D averages every strength and form sold under “Methocarbamol*” / “Methocarbamol” into one figure, so it is not specific to this NDC. The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Methocarbamol* / Methocarbamol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 42 NADAC NDCs the name join matched to it have an FDA route including ORAL. 4 of the 42 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).